Literature DB >> 20142489

Membrane-anchored serine protease matriptase regulates epithelial barrier formation and permeability in the intestine.

Marguerite S Buzza1, Sarah Netzel-Arnett, Terez Shea-Donohue, Aiping Zhao, Chen-Yong Lin, Karin List, Roman Szabo, Alessio Fasano, Thomas H Bugge, Toni M Antalis.   

Abstract

The intestinal epithelium serves as a major protective barrier between the mammalian host and the external environment. Here we show that the transmembrane serine protease matriptase plays a pivotol role in the formation and integrity of the intestinal epithelial barrier. St14 hypomorphic mice, which have a 100-fold reduction in intestinal matriptase mRNA levels, display a 35% reduction in intestinal transepithelial electrical resistance (TEER). Matriptase is expressed during intestinal epithelial differentiation and colocalizes with E-cadherin to apical junctional complexes (AJC) in differentiated polarized Caco-2 monolayers. Inhibition of matriptase activity using a specific peptide inhibitor or by knockdown of matriptase by siRNA disrupts the development of TEER in barrier-forming Caco-2 monolayers and increases paracellular permeability to macromolecular FITC-dextran. Loss of matriptase was associated with enhanced expression and incorporation of the permeability-associated, "leaky" tight junction protein claudin-2 at intercellular junctions. Knockdown of claudin-2 enhanced the development of TEER in matriptase-silenced Caco-2 monolayers, suggesting that the reduced barrier integrity was caused, at least in part, by an inability to regulate claudin-2 expression and incorporation into junctions. We find that matriptase enhances the rate of claudin-2 protein turnover, and that this is mediated indirectly through an atypical PKCzeta-dependent signaling pathway. These results support a key role for matriptase in regulating intestinal epithelial barrier competence, and suggest an intriguing link between pericellular serine protease activity and tight junction assembly in polarized epithelia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20142489      PMCID: PMC2840089          DOI: 10.1073/pnas.0903923107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut.

Authors:  C Rahner; L L Mitic; J M Anderson
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

2.  Characterization of matriptase expression in normal human tissues.

Authors:  Michael D Oberst; Baljit Singh; Metin Ozdemirli; Robert B Dickson; Michael D Johnson; Chen-Yong Lin
Journal:  J Histochem Cytochem       Date:  2003-08       Impact factor: 2.479

3.  Protease inhibitors suppress the formation of tight junctions in gastrointestinal cell lines.

Authors:  A Bacher; K Griebl; S Mackamul; R Mitreiter; H Mückter; Y Ben-Shaul
Journal:  Exp Cell Res       Date:  1992-05       Impact factor: 3.905

4.  Serine proteases decrease intestinal epithelial ion permeability by activation of protein kinase Czeta.

Authors:  Veronica A Swystun; Bernard Renaux; France Moreau; Shoubin Wen; Michael A Peplowski; Morley D Hollenberg; Wallace K MacNaughton
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-05-21       Impact factor: 4.052

5.  Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure.

Authors:  Ramzi El Asmar; Pinaki Panigrahi; Penelope Bamford; Irene Berti; Tarcisio Not; Giovanni V Coppa; Carlo Catassi; Alessio Fasano; Rahzi El Asmar
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

6.  Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis.

Authors:  Karin List; Christian C Haudenschild; Roman Szabo; WanJun Chen; Sharon M Wahl; William Swaim; Lars H Engelholm; Niels Behrendt; Thomas H Bugge
Journal:  Oncogene       Date:  2002-05-23       Impact factor: 9.867

Review 7.  Membrane anchored serine proteases: a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer.

Authors:  Sarah Netzel-Arnett; John D Hooper; Roman Szabo; Edwin L Madison; James P Quigley; Thomas H Bugge; Toni M Antalis
Journal:  Cancer Metastasis Rev       Date:  2003 Jun-Sep       Impact factor: 9.264

Review 8.  Protein kinase Czeta (PKCzeta): activation mechanisms and cellular functions.

Authors:  Takaaki Hirai; Kazuhiro Chida
Journal:  J Biochem       Date:  2003-01       Impact factor: 3.387

9.  CVS-3983, a selective matriptase inhibitor, suppresses the growth of androgen independent prostate tumor xenografts.

Authors:  Anna V Galkin; Lynne Mullen; William D Fox; Jason Brown; David Duncan; Ofir Moreno; Edwin L Madison; David B Agus
Journal:  Prostate       Date:  2004-11-01       Impact factor: 4.104

10.  Atypical protein kinase C is involved in the evolutionarily conserved par protein complex and plays a critical role in establishing epithelia-specific junctional structures.

Authors:  A Suzuki; T Yamanaka; T Hirose; N Manabe; K Mizuno; M Shimizu; K Akimoto; Y Izumi; T Ohnishi; S Ohno
Journal:  J Cell Biol       Date:  2001-03-19       Impact factor: 10.539

View more
  82 in total

Review 1.  Protease-activated receptor 2 signaling in inflammation.

Authors:  Andrea S Rothmeier; Wolfram Ruf
Journal:  Semin Immunopathol       Date:  2011-10-06       Impact factor: 9.623

2.  Transport via the transcytotic pathway makes prostasin available as a substrate for matriptase.

Authors:  Stine Friis; Sine Godiksen; Jette Bornholdt; Joanna Selzer-Plon; Hanne Borger Rasmussen; Thomas H Bugge; Chen-Yong Lin; Lotte K Vogel
Journal:  J Biol Chem       Date:  2010-12-10       Impact factor: 5.157

Review 3.  The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment.

Authors:  Toni M Antalis; Marguerite S Buzza; Kathryn M Hodge; John D Hooper; Sarah Netzel-Arnett
Journal:  Biochem J       Date:  2010-06-15       Impact factor: 3.857

Review 4.  Membrane-anchored proteases in endothelial cell biology.

Authors:  Toni M Antalis; Gregory D Conway; Raymond J Peroutka; Marguerite S Buzza
Journal:  Curr Opin Hematol       Date:  2016-05       Impact factor: 3.284

Review 5.  Membrane-anchored serine proteases in vertebrate cell and developmental biology.

Authors:  Roman Szabo; Thomas H Bugge
Journal:  Annu Rev Cell Dev Biol       Date:  2011-06-29       Impact factor: 13.827

6.  Imaging a functional tumorigenic biomarker in the transformed epithelium.

Authors:  Aaron M LeBeau; Minhee Lee; Stephanie T Murphy; Byron C Hann; Robert S Warren; Romelyn Delos Santos; John Kurhanewicz; Samir M Hanash; Henry F VanBrocklin; Charles S Craik
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

7.  Changes in the distribution of type II transmembrane serine protease, TMPRSS2 and in paracellular permeability in IPEC-J2 cells exposed to oxidative stress.

Authors:  Erzsebet Paszti-Gere; Reka Fanni Barna; Csaba Kovago; Ipoly Szauder; Gabriella Ujhelyi; Csaba Jakab; Nóra Meggyesházi; Andras Szekacs
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

8.  Prostasin is required for matriptase activation in intestinal epithelial cells to regulate closure of the paracellular pathway.

Authors:  Marguerite S Buzza; Erik W Martin; Kathryn H Driesbaugh; Antoine Désilets; Richard Leduc; Toni M Antalis
Journal:  J Biol Chem       Date:  2013-02-26       Impact factor: 5.157

9.  Epithelial cell adhesion molecule (EpCAM) regulates claudin dynamics and tight junctions.

Authors:  Chuan-Jin Wu; Poonam Mannan; Michael Lu; Mark C Udey
Journal:  J Biol Chem       Date:  2013-03-13       Impact factor: 5.157

10.  The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin.

Authors:  Stine Friis; Katiuchia Uzzun Sales; Jeffrey Martin Schafer; Lotte K Vogel; Hiroaki Kataoka; Thomas H Bugge
Journal:  J Biol Chem       Date:  2014-06-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.